JoVE Logo
Faculty Resource Center

Sign In

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

DOI :

10.3791/54714-v

December 9th, 2016

December 9th, 2016

13,314 Views

1Department of Pediatric Oncology/Hematology, VU University Medical Center, 2Department of Hematology, VU University Medical Center, 3Department of Medical Oncology, VU University Medical Center, 4Department of Clinical Genetics, VU University Medical Center, 5Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana, Universita’ di Pisa, 6Amsterdam Immunology and Rheumatology Center, VU University Medical Center, 7Princess Máxima Center for Pediatric Oncology, 8Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, 9Institute of Nanoscience and Nanotechnology, CNR-Nano

Here we describe a protocol aimed at investigating the impact of aberrant splicing on drug resistance in solid tumors and hematological malignancies. To this goal, we analyzed the transcriptomic profiles of parental and resistant in vitro models through RNA-seq and established a qRT-PCR based method to validate candidate genes.

Tags

RNA sequencing

-- Views

Related Videos

article

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

article

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

article

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

article

Evaluating In Vitro DNA Damage Using Comet Assay

article

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

article

In Vitro Assay to Study Tumor-macrophage Interaction

article

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells

article

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

article

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

article

Optimization of Performance Parameters of the TAGGG Telomere Length Assay

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved